{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T12:37:15Z","timestamp":1791722235932,"version":"4.3.4"},"reference-count":90,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministry of Science and ICT, Republic of Korea","award":["NRF-2021R1C1C1012901"],"award-info":[{"award-number":["NRF-2021R1C1C1012901"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background and Hypothesis<\/jats:title>\n                  <jats:p>Schizophrenia involves microstructural changes in white matter (WM) tracts. Oxidative stress is a key factor causing WM damage by hindering oligodendrocyte development and myelin maturation. Uric acid (UA), an endogenous antioxidant, may protect against oxidative stress. We investigated the effect of UA on WM connectivity in antipsychotic-naive or -free patients with early- or chronic-stage schizophrenia.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Study Design<\/jats:title>\n                  <jats:p>A total of 192 patients with schizophrenia (122 recent-onset [ROS] and 70 chronic [CS]) and 107 healthy controls (HCs) participated in this study. Diffusion tensor imaging data and serum UA levels at baseline were obtained.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Study Results<\/jats:title>\n                  <jats:p>Fractional anisotropy was lower in the widespread WM regions across the whole brain, and diffusivity measures were higher in both schizophrenia groups than in HCs. The CS group showed lower diffusivity in some WM tracts than the ROS or HC groups. The linear relationship of serum UA levels with axial and mean diffusivity in the right frontal region was significantly different between schizophrenia stages, which was driven by a negative association in the CS group. WM diffusivity associated with serum UA levels correlated with 8-week treatment responses only in patients with CS, suggesting UA to be protective against long-term schizophrenia.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>UA may protect against the WM damage associated with the progression of schizophrenia by reducing oxidative stress and supporting WM repair against oxidative damage. These results provide insights into the positive role of UA and may facilitate the development of novel disease-modifying therapies.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/schbul\/sbae008","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T17:39:44Z","timestamp":1706809184000},"page":"815-826","source":"Crossref","is-referenced-by-count":6,"title":["Positive Effects of Uric Acid on White Matter Microstructures and Treatment Response in Patients With Schizophrenia"],"prefix":"10.1093","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1669-4014","authenticated-orcid":false,"given":"Minji","family":"Bang","sequence":"first","affiliation":[{"name":"Department of Psychiatry, CHA Bundang Medical Center, CHA University School of Medicine , Seongnam , Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yul","family":"Heo","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, CHA Bundang Medical Center, CHA University School of Medicine , Seongnam , Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tai Kiu","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, CHA Bundang Medical Center, CHA University School of Medicine , Seongnam , Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Hyuk","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, CHA Bundang Medical Center, CHA University School of Medicine , Seongnam , Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,2,1]]},"reference":[{"issue":"1\u20133","key":"2024072716111134700_CIT0001","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.schres.2008.11.021","article-title":"Meta-analysis of diffusion tensor imaging studies in schizophrenia","volume":"108","author":"Ellison-Wright","year":"2009","journal-title":"Schizophr Res."},{"issue":"5","key":"2024072716111134700_CIT0002","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/mp.2017.170","article-title":"Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA Schizophrenia DTI Working Group","volume":"23","author":"Kelly","year":"2018","journal-title":"Mol Psychiatry."},{"issue":"5","key":"2024072716111134700_CIT0003","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1001\/archpsyc.60.5.443","article-title":"White matter changes in schizophrenia: evidence for myelin-related dysfunction","volume":"60","author":"Davis","year":"2003","journal-title":"Arch Gen Psychiatry."},{"issue":"2","key":"2024072716111134700_CIT0004","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/00001504-200503000-00004","article-title":"Evidence for white matter abnormalities in schizophrenia","volume":"18","author":"Kubicki","year":"2005","journal-title":"Curr Opin Psychiatry."},{"issue":"12","key":"2024072716111134700_CIT0005","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1038\/mp.2012.23","article-title":"Neurodevelopmental model of schizophrenia: update 2012","volume":"17","author":"Rapoport","year":"2012","journal-title":"Mol Psychiatry."},{"issue":"2","key":"2024072716111134700_CIT0006","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.pscychresns.2006.09.004","article-title":"Progressive changes of white matter integrity in schizophrenia revealed by diffusion tensor imaging","volume":"154","author":"Mori","year":"2007","journal-title":"Psychiatry Res."},{"issue":"8","key":"2024072716111134700_CIT0007","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1176\/appi.ajp.2008.07101640","article-title":"Diffusion tensor imaging findings in first-episode and chronic schizophrenia patients","volume":"165","author":"Friedman","year":"2008","journal-title":"Am J Psychiatry."},{"issue":"5","key":"2024072716111134700_CIT0008","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.biopsych.2012.10.002","article-title":"Testing the hypothesis of accelerated cerebral white matter aging in schizophrenia and major depression","volume":"73","author":"Kochunov","year":"2013","journal-title":"Biol Psychiatry."},{"key":"2024072716111134700_CIT0009","first-page":"12","article-title":"Selective neuronal vulnerability to oxidative stress in the brain","volume":"2","author":"Wang","year":"2010","journal-title":"Front Aging Neurosci."},{"issue":"2","key":"2024072716111134700_CIT0010","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/(SICI)1098-1136(199606)17:2<83::AID-GLIA1>3.0.CO;2-7","article-title":"Relationship of iron to oligondendrocytes and myelination","volume":"17","author":"Connor","year":"1996","journal-title":"Glia."},{"issue":"3","key":"2024072716111134700_CIT0011","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.neubiorev.2010.10.008","article-title":"Oxidative stress in schizophrenia: an integrated approach","volume":"35","author":"Bitanihirwe","year":"2011","journal-title":"Neurosci Biobehav Rev."},{"issue":"7","key":"2024072716111134700_CIT0012","doi-asserted-by":"crossref","first-page":"e1171","DOI":"10.1038\/tp.2017.138","article-title":"Oxidative stress, prefrontal cortex hypomyelination and cognitive symptoms in schizophrenia","volume":"7","author":"Maas","year":"2017","journal-title":"Transl Psychiatry."},{"issue":"3","key":"2024072716111134700_CIT0013","doi-asserted-by":"crossref","first-page":"pyv110","DOI":"10.1093\/ijnp\/pyv110","article-title":"Glutathione deficit affects the integrity and function of the fimbria\/fornix and anterior commissure in mice: relevance for schizophrenia","volume":"19","author":"Corcoba","year":"2015","journal-title":"Int J Neuropsychopharmacol."},{"issue":"7","key":"2024072716111134700_CIT0014","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1523\/JNEUROSCI.3857-09.2010","article-title":"Redox dysregulation affects the ventral but not dorsal hippocampus: impairment of parvalbumin neurons, gamma oscillations, and related behaviors","volume":"30","author":"Steullet","year":"2010","journal-title":"J Neurosci."},{"issue":"1","key":"2024072716111134700_CIT0015","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/1352458507080111","article-title":"Oxidative stress and excitotoxicity: a therapeutic issue in multiple sclerosis","volume":"14","author":"Gonsette","year":"2008","journal-title":"Mult Scler."},{"issue":"9","key":"2024072716111134700_CIT0016","doi-asserted-by":"crossref","first-page":"11783","DOI":"10.3390\/ijms130911783","article-title":"Mechanisms of oxidative damage in multiple sclerosis and neurodegenerative diseases: therapeutic modulation via fumaric acid esters","volume":"13","author":"Lee","year":"2012","journal-title":"Int J Mol Sci."},{"issue":"1","key":"2024072716111134700_CIT0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-9964(98)00030-9","article-title":"Reduced status of plasma total antioxidant capacity in schizophrenia","volume":"32","author":"Yao","year":"1998","journal-title":"Schizophr Res."},{"issue":"3","key":"2024072716111134700_CIT0018","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0920-9964(02)00407-3","article-title":"Reduced plasma antioxidants in first-episode patients with schizophrenia","volume":"62","author":"Reddy","year":"2003","journal-title":"Schizophr Res."},{"issue":"12","key":"2024072716111134700_CIT0019","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1631\/jzus.2006.B0981","article-title":"Imbalanced free radicals and antioxidant defense systems in schizophrenia: a comparative study","volume":"7","author":"Li","year":"2006","journal-title":"J Zhejiang Univ Sci B."},{"issue":"7","key":"2024072716111134700_CIT0020","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.pnpbp.2009.06.018","article-title":"Decreased glutathione levels and antioxidant enzyme activities in untreated and treated schizophrenic patients","volume":"33","author":"Raffa","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry."},{"issue":"11","key":"2024072716111134700_CIT0021","doi-asserted-by":"crossref","first-page":"4578","DOI":"10.1007\/s12035-020-02047-5","article-title":"Lowered antioxidant defenses and increased oxidative toxicity are hallmarks of deficit schizophrenia: a nomothetic network psychiatry approach","volume":"57","author":"Maes","year":"2020","journal-title":"Mol Neurobiol."},{"issue":"4","key":"2024072716111134700_CIT0022","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s11571-019-09530-3","article-title":"Plasma total antioxidant status and cognitive impairments in first-episode drug-naive patients with schizophrenia","volume":"13","author":"Xie","year":"2019","journal-title":"Cogn Neurodyn."},{"issue":"1\u20133","key":"2024072716111134700_CIT0023","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.schres.2012.04.009","article-title":"Plasma total antioxidant status and cognitive impairments in schizophrenia","volume":"139","author":"Zhang","year":"2012","journal-title":"Schizophr Res."},{"issue":"2","key":"2024072716111134700_CIT0024","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1007\/s13311-021-01036-3","article-title":"Altered antioxidant defenses in drug-naive first episode patients with schizophrenia are associated with poor treatment response to risperidone: 12-week results from a prospective longitudinal study","volume":"18","author":"Li","year":"2021","journal-title":"Neurotherapeutics."},{"issue":"1\u20133","key":"2024072716111134700_CIT0025","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.schres.2012.01.040","article-title":"Decreased glutathione levels predict loss of brain volume in children and adolescents with first-episode psychosis in a two-year longitudinal study","volume":"137","author":"Fraguas","year":"2012","journal-title":"Schizophr Res."},{"issue":"7","key":"2024072716111134700_CIT0026","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/mp.2014.88","article-title":"Glutathione deficit impairs myelin maturation: relevance for white matter integrity in schizophrenia patients","volume":"20","author":"Monin","year":"2015","journal-title":"Mol Psychiatry."},{"issue":"6","key":"2024072716111134700_CIT0027","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1080\/15257770802138558","article-title":"Uric acid: the oxidant-antioxidant paradox","volume":"27","author":"Sautin","year":"2008","journal-title":"Nucleosides Nucleotides Nucleic Acids."},{"issue":"5","key":"2024072716111134700_CIT0028","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.jare.2017.03.003","article-title":"Physiological functions and pathogenic potential of uric acid: a review","volume":"8","author":"El Ridi","year":"2017","journal-title":"J Adv Res."},{"issue":"2","key":"2024072716111134700_CIT0029","first-page":"109","article-title":"A double-edged sword: uric acid and neurological disorders","volume":"2","author":"Fang","year":"2013","journal-title":"Brain Disord Ther."},{"issue":"1","key":"2024072716111134700_CIT0030","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s13311-016-0497-4","article-title":"Urate as a marker of risk and progression of neurodegenerative disease","volume":"14","author":"Paganoni","year":"2017","journal-title":"Neurotherapeutics."},{"issue":"2","key":"2024072716111134700_CIT0031","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1179\/1743132811Y.0000000074","article-title":"Serum uric acid levels in patients with multiple sclerosis: a meta-analysis","volume":"34","author":"Liu","year":"2012","journal-title":"Neurol Res."},{"issue":"2","key":"2024072716111134700_CIT0032","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s004150170246","article-title":"Uric acid levels in sera from patients with multiple sclerosis","volume":"248","author":"Drulovic","year":"2001","journal-title":"J Neurol."},{"issue":"5","key":"2024072716111134700_CIT0033","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jocn.2012.05.054","article-title":"Serum uric acid level in patients with relapsing-remitting multiple sclerosis","volume":"20","author":"Ashtari","year":"2013","journal-title":"J Clin Neurosci."},{"key":"2024072716111134700_CIT0034","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.jad.2017.09.003","article-title":"Uric acid in major depressive and anxiety disorders","volume":"225","author":"Black","year":"2018","journal-title":"J Affect Disord."},{"issue":"1","key":"2024072716111134700_CIT0035","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s12291-010-0016-z","article-title":"Clinical correlation of alteration of endogenous antioxidant-uric acid level in major depressive disorder","volume":"25","author":"Chaudhari","year":"2010","journal-title":"Indian J Clin Biochem."},{"issue":"2","key":"2024072716111134700_CIT0036","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00406-017-0817-7","article-title":"Antioxidant uric acid in treated and untreated subjects with major depressive disorder: a meta-analysis and meta-regression","volume":"268","author":"Bartoli","year":"2018","journal-title":"Eur Arch Psychiatry Clin Neurosci."},{"issue":"6","key":"2024072716111134700_CIT0037","doi-asserted-by":"crossref","first-page":"593","DOI":"10.30773\/pi.2017.12.17","article-title":"Effects of uric acid on the alterations of white matter connectivity in patients with major depression","volume":"15","author":"Sohn","year":"2018","journal-title":"Psychiatry Investig."},{"key":"2024072716111134700_CIT0038","doi-asserted-by":"crossref","first-page":"113305","DOI":"10.1016\/j.psychres.2020.113305","article-title":"Uric acid levels in subjects with schizophrenia: a systematic review and meta-analysis","volume":"292","author":"He","year":"2020","journal-title":"Psychiatry Res."},{"issue":"6","key":"2024072716111134700_CIT0039","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.biopsych.2013.03.018","article-title":"Meta-analysis of oxidative stress in schizophrenia","volume":"74","author":"Flatow","year":"2013","journal-title":"Biol Psychiatry."},{"key":"2024072716111134700_CIT0040","doi-asserted-by":"crossref","first-page":"822579","DOI":"10.3389\/fpsyt.2021.822579","article-title":"Uric acid potential role in systemic inflammation and negative symptoms after acute antipsychotic treatment in schizophrenia","volume":"12","author":"Borovcanin","year":"2021","journal-title":"Front Psychiatry."},{"key":"2024072716111134700_CIT0041","first-page":"281","article-title":"Abnormal laboratory values during the acute and recovery phases in schizophrenic patients: a retrospective study","volume":"6","author":"Nagamine","year":"2010","journal-title":"Neuropsychiatr Dis Treat."},{"issue":"4","key":"2024072716111134700_CIT0042","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1017\/neu.2019.14","article-title":"A five-year follow-up study of antioxidants, oxidative stress and polyunsaturated fatty acids in schizophrenia","volume":"31","author":"Solberg","year":"2019","journal-title":"Acta Neuropsychiatr."},{"key":"2024072716111134700_CIT0043","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2147\/CLEP.S236885","article-title":"Assessment causality in associations between serum uric acid and risk of schizophrenia: a two-sample bidirectional Mendelian randomization study","volume":"12","author":"Luo","year":"2020","journal-title":"Clin Epidemiol."},{"key":"2024072716111134700_CIT0044","volume-title":"Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition","author":"First","year":"2002"},{"key":"2024072716111134700_CIT0045","volume-title":"Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Non-patient Edition","author":"First","year":"2002"},{"key":"2024072716111134700_CIT0046","volume-title":"Structured Clinical Interview for DSM-5 Disorders, Clinician Version","author":"First","year":"2016"},{"issue":"4","key":"2024072716111134700_CIT0047","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1751-7893.2009.00148.x","article-title":"Review of the operational definition for first-episode psychosis","volume":"3","author":"Breitborde","year":"2009","journal-title":"Early Interv Psychiatry."},{"issue":"1","key":"2024072716111134700_CIT0048","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0028-3932(71)90067-4","article-title":"The assessment and analysis of handedness: the Edinburgh inventory","volume":"9","author":"Oldfield","year":"1971","journal-title":"Neuropsychologia."},{"issue":"2","key":"2024072716111134700_CIT0049","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr Bull."},{"issue":"9","key":"2024072716111134700_CIT0050","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1038\/sj.npp.1301325","article-title":"Defining \u2018response\u2019 in antipsychotic drug trials: recommendations for the use of scale-derived cutoffs","volume":"32","author":"Leucht","year":"2007","journal-title":"Neuropsychopharmacology."},{"issue":"5","key":"2024072716111134700_CIT0051","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3174\/ajnr.A1052","article-title":"Diffusion tensor MR imaging and fiber tractography: technical considerations","volume":"29","author":"Mukherjee","year":"2008","journal-title":"AJNR Am J Neuroradiol."},{"key":"2024072716111134700_CIT0052","first-page":"39","article-title":"Practical aspects of diffusion tensor imaging","volume-title":"Introduction to Diffusion Tensor Imaging","author":"Mori","year":"2014","edition":"2"},{"issue":"4","key":"2024072716111134700_CIT0053","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.neuroimage.2006.02.024","article-title":"Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data","volume":"31","author":"Smith","year":"2006","journal-title":"Neuroimage."},{"issue":"6","key":"2024072716111134700_CIT0054","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1002\/mrm.22924","article-title":"Diffusion tensor imaging and beyond","volume":"65","author":"Tournier","year":"2011","journal-title":"Magn Reson Med."},{"key":"2024072716111134700_CIT0055","doi-asserted-by":"crossref","first-page":"S208","DOI":"10.1016\/j.neuroimage.2004.07.051","article-title":"Advances in functional and structural MR image analysis and implementation as FSL","volume":"23","author":"Smith","year":"2004","journal-title":"Neuroimage."},{"issue":"6","key":"2024072716111134700_CIT0056","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/mrm.21890","article-title":"The B-matrix must be rotated when correcting for subject motion in DTI data","volume":"61","author":"Leemans","year":"2009","journal-title":"Magn Reson Med."},{"issue":"3","key":"2024072716111134700_CIT0057","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/hbm.10062","article-title":"Fast robust automated brain extraction","volume":"17","author":"Smith","year":"2002","journal-title":"Hum Brain Mapp."},{"issue":"2","key":"2024072716111134700_CIT0058","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.neuroimage.2011.09.015","article-title":"FSL","volume":"62","author":"Jenkinson","year":"2012","journal-title":"Neuroimage."},{"issue":"100","key":"2024072716111134700_CIT0059","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.neuroimage.2014.01.060","article-title":"Permutation inference for the general linear model","volume":"92","author":"Winkler","year":"2014","journal-title":"Neuroimage."},{"key":"2024072716111134700_CIT0060","volume-title":"Introduction to Mediation, Moderation, and Conditional Process Analysis: A Regression-Based Approach","author":"Hayes","year":"2022","edition":"3"},{"issue":"9","key":"2024072716111134700_CIT0061","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1007\/s10067-018-4130-2","article-title":"Prevalence of hyperuricemia and its associated factors in the general Korean population: an analysis of a population-based nationally representative sample","volume":"37","author":"Kim","year":"2018","journal-title":"Clin Rheumatol."},{"issue":"5","key":"2024072716111134700_CIT0062","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1096\/fasebj.14.5.691","article-title":"Uric acid, a peroxynitrite scavenger, inhibits CNS inflammation, blood-CNS barrier permeability changes, and tissue damage in a mouse model of multiple sclerosis","volume":"14","author":"Hooper","year":"2000","journal-title":"FASEB J."},{"issue":"4","key":"2024072716111134700_CIT0063","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.bbrc.2017.10.004","article-title":"Uric acid demonstrates neuroprotective effect on Parkinson\u2019s disease mice through Nrf2-ARE signaling pathway","volume":"493","author":"Huang","year":"2017","journal-title":"Biochem Biophys Res Commun."},{"issue":"9","key":"2024072716111134700_CIT0064","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1073\/pnas.0500307102","article-title":"Uric acid protects against secondary damage after spinal cord injury","volume":"102","author":"Scott","year":"2005","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"11","key":"2024072716111134700_CIT0065","doi-asserted-by":"crossref","first-page":"6511","DOI":"10.4049\/jimmunol.165.11.6511","article-title":"The peroxynitrite scavenger uric acid prevents inflammatory cell invasion into the central nervous system in experimental allergic encephalomyelitis through maintenance of blood-central nervous system barrier integrity","volume":"165","author":"Kean","year":"2000","journal-title":"J Immunol."},{"issue":"8\u20139","key":"2024072716111134700_CIT0066","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1081\/NCN-200027469","article-title":"Urate oxidation in CSF and blood of patients with inflammatory disorders of the nervous system","volume":"23","author":"Becker","year":"2004","journal-title":"Nucleosides Nucleotides Nucleic Acids."},{"key":"2024072716111134700_CIT0067","doi-asserted-by":"crossref","first-page":"589928","DOI":"10.3389\/fneur.2020.589928","article-title":"Increased cerebrospinal fluid uric acid levels in Guillain-Barre syndrome","volume":"11","author":"Chang","year":"2020","journal-title":"Front Neurol."},{"issue":"1","key":"2024072716111134700_CIT0068","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0021-9150(99)00214-2","article-title":"Uric acid and serum antioxidant capacity: a reaction to atherosclerosis","volume":"148","author":"Nieto","year":"2000","journal-title":"Atherosclerosis."},{"issue":"3","key":"2024072716111134700_CIT0069","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/00005344-200109000-00005","article-title":"Systemic uric acid administration increases serum antioxidant capacity in healthy volunteers","volume":"38","author":"Waring","year":"2001","journal-title":"J Cardiovasc Pharmacol."},{"key":"2024072716111134700_CIT0070","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3389\/fnhum.2014.00653","article-title":"A review of structural neuroimaging in schizophrenia: from connectivity to connectomics","volume":"8","author":"Wheeler","year":"2014","journal-title":"Front Hum Neurosci."},{"key":"2024072716111134700_CIT0071","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.neulet.2018.08.036","article-title":"White matter integrity associated with severity reductions in positive symptoms after amisulpride treatment in drug-free patients with schizophrenia","volume":"685","author":"Cho","year":"2018","journal-title":"Neurosci Lett."},{"issue":"2","key":"2024072716111134700_CIT0072","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1552-6569.2012.00779.x","article-title":"White matter alterations in early stages of schizophrenia: a systematic review of diffusion tensor imaging studies","volume":"24","author":"Samartzis","year":"2014","journal-title":"J Neuroimaging."},{"key":"2024072716111134700_CIT0073","doi-asserted-by":"crossref","first-page":"620401","DOI":"10.3389\/fpsyt.2021.620401","article-title":"Longitudinal structural MRI findings in individuals at genetic and clinical high risk for psychosis: a systematic review","volume":"12","author":"Merritt","year":"2021","journal-title":"Front Psychiatry."},{"issue":"3","key":"2024072716111134700_CIT0074","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1192\/bjp.bp.107.043463","article-title":"White matter volume changes in people who develop psychosis","volume":"193","author":"Walterfang","year":"2008","journal-title":"Br J Psychiatry."},{"issue":"6","key":"2024072716111134700_CIT0075","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1093\/schbul\/sbs053","article-title":"Alterations in white matter evident before the onset of psychosis","volume":"38","author":"Carletti","year":"2012","journal-title":"Schizophr Bull."},{"issue":"8","key":"2024072716111134700_CIT0076","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1017\/S0033291709991711","article-title":"White-matter markers for psychosis in a prospective ultra-high-risk cohort","volume":"40","author":"Bloemen","year":"2010","journal-title":"Psychol Med."},{"issue":"7\u20138","key":"2024072716111134700_CIT0077","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/nbm.782","article-title":"The basis of anisotropic water diffusion in the nervous system\u2014a technical review","volume":"15","author":"Beaulieu","year":"2002","journal-title":"NMR Biomed."},{"key":"2024072716111134700_CIT0078","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3389\/fneur.2018.00092","article-title":"Understanding the physiopathology behind axial and radial diffusivity changes\u2014what do we know","volume":"9","author":"Winklewski","year":"2018","journal-title":"Front Neurol."},{"issue":"7\u20138","key":"2024072716111134700_CIT0079","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/nbm.787","article-title":"Applications of diffusion-weighted and diffusion tensor MRI to white matter diseases\u2014a review","volume":"15","author":"Horsfield","year":"2002","journal-title":"NMR Biomed."},{"issue":"6","key":"2024072716111134700_CIT0080","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/ana.24641","article-title":"Radiological-pathological correlation of diffusion tensor and magnetization transfer imaging in a closed head traumatic brain injury model","volume":"79","author":"Tu","year":"2016","journal-title":"Ann Neurol."},{"issue":"6","key":"2024072716111134700_CIT0081","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1503\/jpn.130280","article-title":"White matter tractography in early psychosis: clinical and neurocognitive associations","volume":"39","author":"Hatton","year":"2014","journal-title":"J Psychiatry Neurosci."},{"issue":"3","key":"2024072716111134700_CIT0082","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00415-004-0348-9","article-title":"The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy","volume":"251","author":"Gilgun-Sherki","year":"2004","journal-title":"J Neurol."},{"issue":"2","key":"2024072716111134700_CIT0083","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00406-017-0788-8","article-title":"In vivo imaging of oxidative stress and fronto-limbic white matter integrity in young adults with mood disorders","volume":"268","author":"Hermens","year":"2018","journal-title":"Eur Arch Psychiatry Clin Neurosci."},{"issue":"16","key":"2024072716111134700_CIT0084","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1097\/00001756-200111160-00052","article-title":"In vivo damage of CNS myelin and axons induced by peroxynitrite","volume":"12","author":"Touil","year":"2001","journal-title":"Neuroreport."},{"issue":"8","key":"2024072716111134700_CIT0085","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.neubiorev.2013.06.015","article-title":"A systematic review of diffusion weighted MRI studies of white matter microstructure in adolescent substance users","volume":"37","author":"Baker","year":"2013","journal-title":"Neurosci Biobehav Rev."},{"issue":"2","key":"2024072716111134700_CIT0086","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s12264-014-1502-8","article-title":"Prefrontal cortex and the dysconnectivity hypothesis of schizophrenia","volume":"31","author":"Zhou","year":"2015","journal-title":"Neurosci Bull."},{"issue":"41","key":"2024072716111134700_CIT0087","doi-asserted-by":"crossref","first-page":"16334","DOI":"10.1523\/JNEUROSCI.0708-13.2013","article-title":"Neonatal E. coli infection causes neuro-behavioral deficits associated with hypomyelination and neuronal sequestration of iron","volume":"33","author":"Lieblein-Boff","year":"2013","journal-title":"J Neurosci."},{"issue":"11","key":"2024072716111134700_CIT0088","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.3390\/cells8111424","article-title":"Oligodendrocytes in development, myelin generation and beyond","volume":"8","author":"Kuhn","year":"2019","journal-title":"Cells."},{"issue":"1","key":"2024072716111134700_CIT0089","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.schres.2014.03.035","article-title":"Glial cells as key players in schizophrenia pathology: recent insights and concepts of therapy","volume":"161","author":"Bernstein","year":"2015","journal-title":"Schizophr Res."},{"issue":"1","key":"2024072716111134700_CIT0090","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.pneurobio.2010.09.004","article-title":"Linking oligodendrocyte and myelin dysfunction to neurocircuitry abnormalities in schizophrenia","volume":"93","author":"Takahashi","year":"2011","journal-title":"Prog Neurobiol."}],"container-title":["Schizophrenia Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/schizophreniabulletin\/article-pdf\/50\/4\/815\/58667277\/sbae008.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/schizophreniabulletin\/article-pdf\/50\/4\/815\/58667277\/sbae008.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T16:13:01Z","timestamp":1722096781000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/schizophreniabulletin\/article\/50\/4\/815\/7596039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,1]]},"references-count":90,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,2,1]]},"published-print":{"date-parts":[[2024,7,27]]}},"URL":"https:\/\/doi.org\/10.1093\/schbul\/sbae008","relation":{},"ISSN":["0586-7614","1745-1701"],"issn-type":[{"value":"0586-7614","type":"print"},{"value":"1745-1701","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,7]]},"published":{"date-parts":[[2024,2,1]]}}}